SUMMARY Inhalation of 100% oxygen by nine children with pulmonary vascular disease increased pulmonary blood flow measured at cardiac catheterisation; there was no significant change in pulmonary artery pressure. Fifteen children with pulmonary vascular disease that was severe enough to preclude corrective cardiac operation were studied to determine the effect of long term oxygen treatment on pulmonary vascular disease. Nine received long term domiciliary oxygen for a minimum of twelve hours a day for up to five years. Though the untreated group closely resembled the treated group their survival was significantly less good. All nine treated children are alive whereas five of the six children who did not receive oxygen have died.
Pulmonary vascular resistance is often raised in children with congenital heart defects and is always raised in those with primary pulmonary hypertension, which is a rare condition. In many such children the pulmonary vascular resistance can be reduced by a pulmonary vasodilator such as oxygen, tolazoline, or epoprostenol (prostacyclin). But when the resistance remains >8 mm Hg.l -'.min.m2 (640 dyn.s.cm-5.m2) during optimal ventilation with 100% oxygen, surgical repair of the cardiac defect is associated with an unacceptably high risk of perioperative death or may lead to accelerated deterioration in the pulmonary vascular bed.' 2 These children have hypertensive pulmonary vascular disease, and pathological changes in the pulmonary arterioles are invariably found at biopsy.34 They also have reduced exercise tolerance and a poor prognosis. At present there is no effective and accepted treatment.
Measurements during cardiac catheterisation (both published5 and our own which are described below) show that in all cases that were studied inhalation of 100% oxygen produced some fall in pulmonary vascular resistance compared with that in air. This shows that there is an additional but
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Accepted for publication 10 December 1985 reversible element of vasoconstriction contributing to the raised pulmonary vascular resistance and superimposed on the permanent (irreversible) destructive or obliterative changes in the vascular bed. 4 Experimental use of crotalaria alkaloids in rats shows that they cause intense pulmonary vasoconstriction followed by obliteration with fibrinoid necrosis.6 Wagenvoort and Wagenvoort infer from this, and from the charactertistic siting of the obliterative lesions in patients, that fibrinoid necrosis may be the result of intense vasospasm both in children with primary pulmonary hypertension and in those with intracardiac shunts. 4 The response to oxygen and the relation of vasospasm to tissue damage suggested that prolonged oxygen treatment might benefit children with persistently raised pulmonary vascular resistance. The hypothesis on which the trial was based is that the local pharmacological effect of oxygen in relieving vasospasm might prevent or delay a cycle of increasing damage in which superimposed (reversible) vasoconstriction would accelerate destructive changes. The trial was prompted by the pronounced improvement noted in two girls with pulmonary vascular disease and cyanosis who had been using domiciliary oxygen for two or three years when the trial began. They continue to use it but are not included in the trial.
By analogy with studies at altitude7 and the trials of oxygen treatment in patients with chronic Table 1 shows the underlying diagnosis, mean pulmonary artery pressure, and pulmonary vascular resistance measured during cardiac catheterisation.
The treatment and non-treatment groups both contained one child with primary pulmonary hypertension and one child with pulmonary hypertension persisti-ng after operation. Mean age at entry to the trial was similar in the two groups.
The mean pulmonary artery pressures, which where possible were measured both in air and oxygen, are similar in the two groups. Pulmonary vascular resistance was not measured in all patients. Mean pulmonary vascular resistance both in air and oxygen (Table 1 ) was higher in the untreated group, but these differences did not achieve statistical significance (unpaired t test, p > 0 1 for both).
At every visit the parents answered two questionnaires designed to assess the child's disability. The first (Table 2 ) assessed exercise tolerance and the second ( Table 3 ) the extent of troublesome symptoms. A high score suggests subjective well-being. Effect of long term oxygen treatment at home in children with pulmonary vascular disease Results Figure 1 shows the mean pulmonary artery pressures and pulmonary blood flow in the nine children studied in air and oxygen. There was no significant change in pressure on oxygen, but pulmonary blood flow was consistently increased. This is reflected in the reduction of pulmonary vascular resistance when oxygen was breathed, though this did not fall below 8mm Hg.1-.min.m2 (-640 dyn.s.cm-5.m2) in any case.
Acceptability of treatment Three children have used nasal cannulas throughout their treatment, four prefer a mask, and the others can only use a tent. Because the equipment can be used in both the bedroom and sitting room, the child's freedom is less restricted. In some cases the provision of oxygen concentrators was delayed for up to 10 months.
Compliance Four of the nine children complied well with oxygen treatment. These families chose never to go away, or only go away with an alternative oxygen source.
Breakdowns accounted for a maximum of only a week missed per year. These four patients used oxygen for at least 12 hours per day (commonly 14 Effect of long term oxygen treatment at home in children with pulmonary vascular disease 389 hours). Three of the families reported missing up to three weeks a year due to holidays or breakdowns or both. Otherwise these children appear to have had a steady nightly intake of between 10 and 12 hours. All these seven children seem to tolerate treatment well. But two children have found compliance difficult. After two years of successful treatment one adolescent girl found that treatment was intolerable for a four month period during the summer. For a year a boy, who is now fourteen years old and had tolerated treatment for four years, did not comply with treatment. His parents, feeling that his own perception of the quality of his life was paramount, have agreed to his stopping oxygen treatment. Survival Figure 2 shows the survival of the children in the two groups. All nine children on oxygen treatment are alive whereas five of the six children not on treatment have died (X2=9-0, p<0-01 with Yates's cor- rection). In one child death was thought to be due to a sudden arrhythmia, and another child died after a severe chest infection. Three others became unwell over a period of one to three weeks with increasing cyanosis and exercise intolerance. Only one showed signs of congestive right ventricular failure.
Discussion
We have shown that there is an additional reversible vasoconstrictive component in most children with severe pulmonary vascular disease. This vasoconstriction can be minimised by optimal ventilation and added oxygen, and is exacerbated by hypoventilation or acidosis. To avoid unwarranted classification of such cases as inoperable, cardiac output must be initially measured under optimal conditions. Figure 1 shows that reliance on changes in pressure alone will lead to important haemodynamic changes being missed. More studies of this type are needed both to define more accurately the risks of operation at different levels of vascular resistance and to determine the correlation between resistance levels and pathological changes in the lungs. If despite optimal ventilation the pulmonary vascular resistance remains high, operation is contraindicated, and the likely course is one of progressive deterioration. Figure 2 shows that this deterioration can be modified, and survival can be improved.
Deterioration in children with the Eisenmenger complex is associated with increasing right to left shunting which results in a critically low pulmonary blood flow rather than in congestive failure of the right ventricle. There is therefore no reason to suppose that effective pulmonary vasodilatation in this situation causes increased right ventricular work.
This small pilot study shows that long term oxygen treatment at home is well tolerated and improved survival of children with pulmonary vascular disease over a five year period. We believe that the results warrant a larger trial, perhaps at several centres. Recruitment into the trial must be preceded by accurate measurements of pulmonary blood flow under optimal and controlled conditions. 
